Novavax | NVAX - Interest Income


Novavax reported $303K in Interest Income for its fiscal quarter ending in December of 2021.





Interest Income Change Date
Adma Biologics USD 1.09M 717K Mar/2026
AstraZeneca USD 80M 7M Jun/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Cassava Sciences USD 1.17M 47K Sep/2025
Geron USD 3.42M 624K Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
MannKind USD 1.43M 208K Mar/2026
Merck USD 35M 34M Mar/2026
Moderna USD 72M 2M Mar/2026
Novavax USD 303K 27K Dec/2021
Pfizer USD -0.04 115M Jun/2026
Sanofi EUR 77M 17M Jun/2026
Sarepta Therapeutics USD 7M 1.74M Mar/2026